pifithrin has been researched along with Cardiometabolic Syndrome in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity and the metabolic syndrome have evolved to be major health issues throughout the world." | 1.42 | Ablation of XP-V gene causes adipose tissue senescence and metabolic abnormalities. ( Chen, YW; Chou, KM; Harris, RA; Hatahet, Z, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YW | 1 |
| Harris, RA | 1 |
| Hatahet, Z | 1 |
| Chou, KM | 1 |
1 other study available for pifithrin and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Ablation of XP-V gene causes adipose tissue senescence and metabolic abnormalities.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Benzothiazoles; Blood Glucose; Cellular Senescenc | 2015 |